These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5570964)

  • 21. Dose calibration studies of lenperone, a new tranquilizer for dogs, cats and swine.
    Cloyd GD; Gilbert DL
    Vet Med Small Anim Clin; 1973 Apr; 68(4):344 passim. PubMed ID: 4487932
    [No Abstract]   [Full Text] [Related]  

  • 22. Akathisia: a side effect to be remembered.
    Raskin DE
    Am J Psychiatry; 1972 Sep; 129(3):345-7. PubMed ID: 5053718
    [No Abstract]   [Full Text] [Related]  

  • 23. [Observations on the body experience and motor behavior of schizophrenics during neuroleptic therapy].
    Vella G; Ciani N
    Osp Psichiatr; 1965; 33(4):481-90. PubMed ID: 4381125
    [No Abstract]   [Full Text] [Related]  

  • 24. Learning deficits in 4 weeks old offspring of the nursing mothers treated with the neuroleptic drug penfluridol.
    Ahlenius S; Brown R; Engel J; Lundborg P
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(1):31-7. PubMed ID: 4270737
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
    Deniker P; Ginestet D
    Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
    [No Abstract]   [Full Text] [Related]  

  • 26. The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Feb; 25(2):138-46. PubMed ID: 4154850
    [No Abstract]   [Full Text] [Related]  

  • 27. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 4: studies on subacute and chronic toxicity and the effect on reproductive processes in rats, dogs and rabbits.
    Marsboom R; Hérin V; Verstraeten A; Vandesteene R; Fransen J
    Arzneimittelforschung; 1974 Oct; 24(10):1645-9. PubMed ID: 4479778
    [No Abstract]   [Full Text] [Related]  

  • 28. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H; Lange J
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxicity studies on mephenoxalone in rats and dogs.
    BENITZ KF; MORASKI R; ROEPKE RR; WOZNIAK LA
    Toxicol Appl Pharmacol; 1962 Mar; 4():220-37. PubMed ID: 13867249
    [No Abstract]   [Full Text] [Related]  

  • 30. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
    Berchtold P; Hinssen M; Irmscher K
    Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333
    [No Abstract]   [Full Text] [Related]  

  • 31. Extrapyramidal and other effects induced by neuroleptic agents.
    Gunn DR
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:130-40. PubMed ID: 6051719
    [No Abstract]   [Full Text] [Related]  

  • 32. [Late complications in neuroleptic therapy].
    Viukari M
    Duodecim; 1976; 92(4):159-62. PubMed ID: 1253746
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulman FG: Mammotropic and neuroleptic effects of butyrophenones in the rat.
    Mishkinsky J; Khazen K; Givant Y; Dikstein S
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):94-105. PubMed ID: 5388566
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical study of a new neuroleptic, R 2028 or haloanisone].
    DE RYCK A
    Acta Neurol Psychiatr Belg; 1962 Jun; 62():589-603. PubMed ID: 14026044
    [No Abstract]   [Full Text] [Related]  

  • 35. [The neuroleptic syndrome].
    Ostaptzeff G; Ostaptzeff-Lavoine M
    Ann Med Psychol (Paris); 1970 Nov; 2(4):614-7. PubMed ID: 5503374
    [No Abstract]   [Full Text] [Related]  

  • 36. [Post-neuroleptic late dyskinesia].
    Villeneuve A; Lavallée JC; Lemieux LH
    Laval Med; 1969 Nov; 40(9):832-7. PubMed ID: 5366584
    [No Abstract]   [Full Text] [Related]  

  • 37. [Individual predisposition for unusual extrapyramidal side effects with neuroleptic agents].
    Lingjaerde O
    Tidsskr Nor Laegeforen; 1971 May; 91(13):977-9. PubMed ID: 5576970
    [No Abstract]   [Full Text] [Related]  

  • 38. Persistence of neurological symptoms due to neuroleptic drugs.
    Crane GE
    Am J Psychiatry; 1971 Apr; 127(10):1407-10. PubMed ID: 5549937
    [No Abstract]   [Full Text] [Related]  

  • 39. [A NEW MAJOR NEUROLEPTIC AGENT: TRIPERIDOL. 1ST CLINICAL RESULTS OBTAINED WITH A NEW BUTYROPHENONE DERIVATIVE].
    DUBOIS C; DICK P; REY-BELLET J
    Schweiz Med Wochenschr; 1963 Nov; 93():1600-4. PubMed ID: 14153115
    [No Abstract]   [Full Text] [Related]  

  • 40. Risks vs. benefits of antipsychotic drugs.
    Baldessarini RJ; Lipinski JF
    N Engl J Med; 1973 Aug; 289(8):427-8. PubMed ID: 4146359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.